Katja Pajula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katja Pajula has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Ossi Korhonen
School of Pharmacy, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland
5 shared publicationsVesa-Pekka Lehto
Department of Applied Physics, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland
3 shared publicationsJarkko Ketolainen
School of Pharmacy, University of Eastern Finland, POB 1627, FI-70211 Kuopio, Finland
2 shared publicationsArto Koistinen
SIB Labs, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland
1 shared publication- Arto Koistinen
Department of Technical Physics, University of Eastern Finland, PO Box 1627, Kuopio FI-70211, Finland
1 shared publication Eetu Valkama
School of Pharmacy, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland
1 shared publication
Latest Publications
- Open Access
- 1 September 2021
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 606, 120902
Production and stability of amorphous solid dispersions produced by a Freeze-drying method from DMSO
- 1 September 2021
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 606, 120902
Open AccessProduction and stability of amorphous solid dispersions produced by a Freeze-drying method from DMSO
- 1 October 2020
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 155, 49-54
Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems
- 1 October 2020
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 155, 49-54
Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems
- 1 May 2020
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 150, 43-49
Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS
- 1 May 2020
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 150, 43-49
Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS
- 23 May 2014
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 11 (7) , 2271-2279
Phase Separation in Coamorphous Systems: in Silico Prediction and the Experimental Challenge of Detection
Combinatorial chemistry has enabled the production of very potent drugs that might otherwise suffer from poor solubility and low oral bioavailability. One approach to increase solubility is to make the drug amorphous, which leads to problems associated with drug stability. To improve stability, one option is to molecularly disperse the drug in a matrix. However, the primary reason for the failed stabilization with this approach is phase separation, which has been carefully studied in polymeric systems. Nevertheless, the amorphous–amorphous phase separation in coamorphous small molecule mixtures has not yet been reported. The goal of the present study was to experimentally detect the amorphous–amorphous phase separation between two small molecules. A modified in silico method for predicting miscibility by the Flory–Huggins interaction parameter is presented, where conformational variations of the studied molecules were taken into account. A series of drug–drug mixtures, with different mixture ratios, were analyzed by conventional differential scanning calorimetry (DSCconv) to detect possible amorphous–amorphous phase separations. The phase separation of coamorphous drug–drug mixtures was also monitored by temperature modulated DSC (MDSC) and Fourier transform infrared (FT-IR) imaging at temperatures above Tg for prolonged time periods. Amorphous–amorphous phase separation was not detected with DSCconv, probably due to the slow kinetics of phase separation. However, the melting of the separated and subsequently crystallized phases was detected by MDSC. Furthermore, FT-IR imaging was able to detect the separation of the two amorphous phases, which demonstrates the ability of this method to detect small molecule phase separations.
- 23 May 2014
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 11 (7) , 2271-2279
Phase Separation in Coamorphous Systems: in Silico Prediction and the Experimental Challenge of Detection
Combinatorial chemistry has enabled the production of very potent drugs that might otherwise suffer from poor solubility and low oral bioavailability. One approach to increase solubility is to make the drug amorphous, which leads to problems associated with drug stability. To improve stability, one option is to molecularly disperse the drug in a matrix. However, the primary reason for the failed stabilization with this approach is phase separation, which has been carefully studied in polymeric systems. Nevertheless, the amorphous–amorphous phase separation in coamorphous small molecule mixtures has not yet been reported. The goal of the present study was to experimentally detect the amorphous–amorphous phase separation between two small molecules. A modified in silico method for predicting miscibility by the Flory–Huggins interaction parameter is presented, where conformational variations of the studied molecules were taken into account. A series of drug–drug mixtures, with different mixture ratios, were analyzed by conventional differential scanning calorimetry (DSCconv) to detect possible amorphous–amorphous phase separations. The phase separation of coamorphous drug–drug mixtures was also monitored by temperature modulated DSC (MDSC) and Fourier transform infrared (FT-IR) imaging at temperatures above Tg for prolonged time periods. Amorphous–amorphous phase separation was not detected with DSCconv, probably due to the slow kinetics of phase separation. However, the melting of the separated and subsequently crystallized phases was detected by MDSC. Furthermore, FT-IR imaging was able to detect the separation of the two amorphous phases, which demonstrates the ability of this method to detect small molecule phase separations.
- 27 August 2012
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 9 (10) , 2844-2855
Computational Approach for Fast Screening of Small Molecular Candidates To Inhibit Crystallization in Amorphous Drugs
The applicability of the computational docking approach was investigated to create a novel method for quick additive screening to inhibit the crystallization taking place in amorphous drugs. Surface energy and attachment energy were utilized to recognize the morphologically most important crystal faces. The surfaces (100), (001), and (010) were identified as target faces, and the estimated free energies of binding of additives on these surfaces were computationally determined. The molecule of the crystallizing compound was included in the group of the modeled additives as the reference and for the validation of the approach. Additives having a lower estimated free energy of binding than the reference molecule itself were considered as potential crystallization inhibitors. Salicylamide, salicylic acid, and sulfanilamide with computationally prescreened additives were melt-quenched, and the nucleation and crystal growth rates were subsequently monitored by polarized light microscopy. As a result, computationally screened additives decelerated the nucleation and crystal growth rates of the studied drugs while the pure drugs crystallized too fast to be measured. The use of a computational approach enabled fast and cost-effective additive selection to retard nucleation and crystal growth, thus facilitating the production of amorphous binary small molecular compounds with stabilized disordered structures.
- 27 August 2012
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 9 (10) , 2844-2855
Computational Approach for Fast Screening of Small Molecular Candidates To Inhibit Crystallization in Amorphous Drugs
The applicability of the computational docking approach was investigated to create a novel method for quick additive screening to inhibit the crystallization taking place in amorphous drugs. Surface energy and attachment energy were utilized to recognize the morphologically most important crystal faces. The surfaces (100), (001), and (010) were identified as target faces, and the estimated free energies of binding of additives on these surfaces were computationally determined. The molecule of the crystallizing compound was included in the group of the modeled additives as the reference and for the validation of the approach. Additives having a lower estimated free energy of binding than the reference molecule itself were considered as potential crystallization inhibitors. Salicylamide, salicylic acid, and sulfanilamide with computationally prescreened additives were melt-quenched, and the nucleation and crystal growth rates were subsequently monitored by polarized light microscopy. As a result, computationally screened additives decelerated the nucleation and crystal growth rates of the studied drugs while the pure drugs crystallized too fast to be measured. The use of a computational approach enabled fast and cost-effective additive selection to retard nucleation and crystal growth, thus facilitating the production of amorphous binary small molecular compounds with stabilized disordered structures.